PDL BioPharma, Inc. Depreciation & Amortization

Depreciation & Amortization of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation & Amortization growth rates and interactive chart.


Highlights and Quick Summary

  • Depreciation & Amortization for the quarter ending June 29, 2020 was $1.09 Million (a -16.88% decrease compared to previous quarter)
  • Year-over-year quarterly Depreciation & Amortization decreased by -84.78%
  • Annual Depreciation & Amortization for 2019 was $17.4 Million (a -35.85% decrease from previous year)
  • Annual Depreciation & Amortization for 2018 was $27.1 Million (a -28.76% decrease from previous year)
  • Annual Depreciation & Amortization for 2017 was $38.1 Million (a 72.72% increase from previous year)
  • Twelve month Depreciation & Amortization ending June 29, 2020 was $13.4 Million (a -13.55% decrease compared to previous quarter)
  • Twelve month trailing Depreciation & Amortization decreased by -24.02% year-over-year
Trailing Depreciation & Amortization for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$13.4 Million $15.5 Million $17.4 Million $17.6 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation & Amortization of PDL BioPharma, Inc.

Most recent Depreciation & Amortizationof PDLI including historical data for past 10 years.

Interactive Chart of Depreciation & Amortization of PDL BioPharma, Inc.

PDL BioPharma, Inc. Depreciation & Amortization for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $1.09 $1.31
2019 $3.85 $7.15 $3.19 $3.22 $17.41
2018 $4.08 $4.44 $9.19 $9.43 $27.14
2017 $9.98 $9.96 $9.39 $8.76 $38.09
2016 $9.96 $8.07 $1.56 $2.47 $22.06
2015 $3.23 $2.54 $3.15 $4.08 $13.0
2014 $5.23 $3.86 $4.7 $4.77 $18.56
2013 $3.36 $3.22 $3.04 $3.3 $12.92
2012 $3.34 $3.5 $3.84 $3.97 $14.65
2011 $2.95 $3.63 $2.39 $2.36 $11.32
2010 $2.29 $2.24 $2.31 $9.25

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.